Abstract | BACKGROUND: METHODS: RESULTS: Mean age and body mass index of patients were 47.0 ± 9.0 years, 22.2 ± 3.0 kg/m(2) and 55.5 ± 10.1 years, 23.0 ± 3.6 kg/m(2) in IBR group and non-IBR group, respectively. Postoperative complication rate was 10.0 % in IBR group and 6.1 % in non-IBR group. Days to adjuvant chemotherapy was 61.0 ± 10.5 days in IBR group and 58.0 ± 12.3 days in non-IBR group. CONCLUSIONS:
|
Authors | Atsumori Hamahata, Kazuyuki Kubo, Hiroyuki Takei, Takashi Saitou, Yuji Hayashi, Hiroshi Matsumoto, Shigenori Nagai, Kenichi Inoue, Masafumi Kurosumi, Takashi Yamaki, Hiroyuki Sakurai |
Journal | Breast cancer (Tokyo, Japan)
(Breast Cancer)
Vol. 22
Issue 3
Pg. 287-91
(May 2015)
ISSN: 1880-4233 [Electronic] Japan |
PMID | 23756827
(Publication Type: Clinical Trial, Journal Article)
|
Topics |
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Breast Neoplasms
(drug therapy, surgery)
- Chemotherapy, Adjuvant
- Combined Modality Therapy
- Female
- Follow-Up Studies
- Humans
- Mammaplasty
- Middle Aged
- Neoplasm Staging
- Postoperative Complications
- Prognosis
- Retrospective Studies
- Time Factors
|